The treatment of acne vulgaris with low dosage doxycycline

Acta Dermatovenerologica Croatica

Volumn 13, Issue 3, 2005, Pages 156-159

  Parish, Lawrence Charles ^a,b,d   Parish, Jennifer L ^a,b   Routh, Hirak B ^b   Witkowski, Joseph A ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Paddington Testing Company Inc   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NONE   (United States)

Author keywords

Acne vulgaris; Inflammatory acne; Subantimicrobial dosing of doxycycline

Indexed keywords

DOXYCYCLINE; DOXYCYCLINE HYCLATE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LOW DRUG DOSE; MALE; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 27744454725     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Parish LC, Crissey JT. Hunch, chance, and serendipity in dermatologie research. In: Epstein E, editor. Controversies in dermatology. Philadelphia: WB Saunders; 1984.p461-5.
2. Sulzberger MB, Baer RL. The year book of dermatology and syphilology (1954-1955 Year Book Series). Chicago: The Year Book Publishers; 1955.
3. Meynadier J, Alirezai M. Systemic antibiotics for acne. Dermatology 1998;196:135-9.
4. Plewig G, Petrozzi JW, Berendes U. Double-blind study of doxycycline in acne vulgaris. Arch Dermatol 1970;101:435-8.
5. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 2004;22:394-7.
6. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:143-52.
7. Parish LC, Witkowski JA. Bacteriology and acne, Int J Dermatol 1984;23:36-7.
8. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology 2003;206:54-6.
9. Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003;139:459-64.
10. Levy RM, Huang EY, Roling D, Leyden JJ, Margolis DJ. Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol 2003;139:467-71.
11. Gencosmanoglu R, Kurtkaya-Yapicier O, Tiftikci A, Avsar E, Tozun N, Oran ES. Midesophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury. J Clin Gastroenterol 2004;38:484-9.
12. Friedman DI, Gordon LK, Egan RA, Jacobson DM, Pomeranz H, Harrison AR, et al. Doxycycline and intracranial hypertension. Neurology 2004;62:2297-9.
13. Passier A, Smits-van Herwaarden A, van Puijenbroek E. Photo-onycholysis associated with the use of doxycycline. BMJ 2004;329:265.